News FDA Wants More Info on Avedro’s Corneal Cross-Linking NDA by Medscape • 2014/03/20 • 0 Comments Company chief executive officer is 'confident' the issues surrounding riboflavin ophthalmic solution/KXL System for keratoconus and corneal ectasia after refractive surgery can be resolved. Medscape Medical News Full Story →